ProfileGDS4132 / 206196_s_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 58% 57% 61% 67% 60% 60% 61% 55% 63% 63% 63% 60% 59% 68% 68% 66% 50% 67% 65% 63% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 101161.02358
GSM201543Muscle PCOS pioglitazone 121150.02457
GSM201544Muscle PCOS pioglitazone 161175.81861
GSM201545Muscle PCOS pioglitazone 201207.35367
GSM201829Muscle PCOS pioglitazone 231176.29560
GSM201830Muscle PCOS pioglitazon 251173.43260
GSM201831Muscle PCOS pioglitazone 271176.12561
GSM201832Muscle PCOS pioglitazone 31145.40255
GSM201833Muscle PCOS pioglitazone 41167.50363
GSM201834Muscle PCOS pioglitazone 81176.53463
GSM201835Muscle PCOS after pioglitazone 102168.23263
GSM201836Muscle PCOS after pioglitazone 122157.00660
GSM201837Muscle PCOS after pioglitazone 162145.58859
GSM201838Muscle PCOS after pioglitazone 202193.25468
GSM201839Muscle PCOS after pioglitazone 232199.28968
GSM201840Muscle PCOS after pioglitazone 252190.31666
GSM201841Muscle PCOS after pioglitazone 272119.25750
GSM201842Muscle PCOS after pioglitazone 32167.98267
GSM201843Muscle PCOS after pioglitazone 42181.62565
GSM201844Muscle PCOS after pioglitazone 82181.47663